Growth hormone and insulin growth factor-I levels in plasma and cerebrospinal fluid of patients with multiple sclerosis

Clinical Neurology and Neurosurgery

Volumn 108, Issue 3, 2006, Pages 255-258

  Poljakovic, Zdravka ^a   Zurak, Niko ^a   Brinar, Vesna ^a   Korsic, Mirko ^a   Basic, Silvio ^a   Hajnsek, Sanja ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cerebrospinal fluid; Growth factors; Growth hormone; Multiple sclerosis

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN;

CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HUMAN; MULTIPLE SCLEROSIS; NEUROPROTECTION; REMYELINIZATION;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MULTIPLE SCLEROSIS;

EID: 33644632315     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2005.11.014     Document Type: Conference Paper

References (24)

1. A. Compston, G. Ebers, and H. Lassmann Neurobiology of multiple sclerosis A. Compston G. Ebers H. Lassmann McAlpine's multiple sclerosis 1999 Churchill Livingstone Edinburgh 283 316
2. F. McMorris, and R. McKinnon Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease Brain Pathol 6 1997 313 329
3. D. Miller, K. Asakura, and M. Rodriguez Central nervous system remyelination clinical application of basic neuroscience principles Brain Pathol 6 1997 331 344
4. M. Carson, R. Behringer, and R. Brinster Insulin-like growth factor I increases brain growth and central nervous system myelinisation in transgenic mice Neuron 10 1993 729 740
5. M. Dubois-Dalcq, and K. Murray Why are growth factors important in oligodendrocate physiology? Pathol Biol 48 2000 80 86
6. F. McMorris, T. Smith, and S. DeSalco Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development Proc Natl Acad Sci USA 83 1986 822 826
7. D. LeRoith, and C. Roberts Jr. Insulin-like growth factors Ann N Y Acad Sci 692 1993 1 9
8. S. Harvey, and K. Hull Neural growth hormone: an update J Mol Neurosci 20 2003 1 14
9. F. Nyberg, and P. Burman Growth hormone and its receptors in the central nervous system-location and functional significance Horm Res 45 1996 18 22
10. R. Ajo, L. Cacicedo, and C. Navarro Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat Endocrinology 144 2003 1086 1097
11. A. Root, and F. Diamond Regulation and clinical assessment of growth hormone secretion Endocrine 12 2000 137 145
12. H. Schneider, U. Pagotto, and G. Stalla Central effects of the somatotropic system Eur J Endocrinol 149 2003 377 392
13. K. Ozawa, G. Suchanek, and H. Breitschopf Patterns of oligodendroglia pathology in multiple sclerosis Brain 117 1994 1311 1322
14. J. Prineas, E. Kwon, and P. Goldenberg Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions Lab Invest 61 1989 489 503
15. W. Blum, W. Albertsson, and S. Rosberg Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion J Clin Endocrinol Metab 76 1993 1610 1616
16. J. Linfoot, J. Garcia, and W. Wei Human growth hormone levels in cerebrospinal fluid J Clin Endocrinol Metab 31 1970 230 232
17. C. Poser, and B. Brinar Diagnostic criteria for multiple sclerosis Neurol Croat 49 2000 21 42
18. L. Jacoby Endocrine diagnosis: clinical and laboratory approach 1983 Little Brown Boston p. 15-51
19. C. Matute, E. Alberdi, and M. Domercq The link between excitotoxic oligodendroglial death and demyelinating diseases Trends Neurosci 24 2001 224 230
20. D. Werring, G. Griffin, and C. Miller Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis J Neurol 250 2003 22 28
21. O. Ciccarelli, D. Werring, and G. Barker A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging - evidence of Wallerian degeneration J Neurol 250 2003 287 292
22. T. Barreca, R. Franceschini, and C. Siani Diurnal changes of plasma and cerebrospinal fluid somatostatin and 24-h growth hormone secretory pattern in man. A study in hydrocephalic patients Acta Endocrinol 117 1988 130 134
23. J. Johansson, G. Larson, and M. Andersson Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters Neuroendocrinology 61 1995 57 66
24. J. Verhelst, R. Abs, and M. Vandeweghe Two years of replacement therapy in adults with growth hormone deficiency Neurology 47 1997 485 494